These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33714744)

  • 1. Thromboembolism in Heart Failure Patients in Sinus Rhythm: Epidemiology, Pathophysiology, Clinical Trials, and Future Direction.
    Lin AY; Dinatolo E; Metra M; Sbolli M; Dasseni N; Butler J; Greenberg BH
    JACC Heart Fail; 2021 Apr; 9(4):243-253. PubMed ID: 33714744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation in Patients with Heart Failure and Sinus Rhythm.
    Li X; Yang J; Xu D
    Int Heart J; 2020 Nov; 61(6):1204-1211. PubMed ID: 33191346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Shantsila E
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD003336. PubMed ID: 24683002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation Therapy and NOACs in Heart Failure.
    Thomas I; EncisoSilva J; Schlueter M; Greenberg B
    Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?
    Rivas A; Lauw MN; Schnabel RB; Crowther M; Van Spall HGC
    Thromb Haemost; 2022 Jun; 122(6):871-878. PubMed ID: 35045579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003336. PubMed ID: 11687190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial.
    Greenberg B; Neaton JD; Anker SD; Byra WM; Cleland JGF; Deng H; Fu M; La Police DA; Lam CSP; Mehra MR; Nessel CC; Spiro TE; van Veldhuisen DJ; Vanden Boom CM; Zannad F
    JAMA Cardiol; 2019 Jun; 4(6):515-523. PubMed ID: 31017637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials.
    Proietti M; Lip GY
    Am J Med; 2016 Oct; 129(10):1110-6. PubMed ID: 27086494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice.
    Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P
    Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003333. PubMed ID: 11687189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Westenbrink BD; Alings M; Granger CB; Alexander JH; Lopes RD; Hylek EM; Thomas L; Wojdyla DM; Hanna M; Keltai M; Steg PG; De Caterina R; Wallentin L; van Gilst WH
    Am Heart J; 2017 Mar; 185():140-149. PubMed ID: 28267467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
    Thibault B; Talajic M; Dubuc M; Guerra P; Gagné P; Roy D; Connolly S;
    Can J Cardiol; 2004 Feb; 20(2):195-9. PubMed ID: 15010743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention.
    De Lorenzo F; Saba N; Kakkar VV
    Drugs; 2003; 63(6):565-76. PubMed ID: 12656654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure.
    Garg RK; Gheorghiade M; Jafri SM
    Prog Cardiovasc Dis; 1998; 41(3):225-36. PubMed ID: 9872608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood Coagulation Disorders in Heart Failure: From Basic Science to Clinical Perspectives.
    Siniarski A; Gąsecka A; Borovac JA; Papakonstantinou PE; Bongiovanni D; Ehrlinder H; Giustozzi M; Guerreiro RA; Parker WAE
    J Card Fail; 2023 Apr; 29(4):517-526. PubMed ID: 36632933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
    Middlekauff HR; Stevenson WG; Gornbein JA
    Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.